What is the generic price for Brilinta (ticagrelor)?
Generic “Brilinta” pricing depends on the exact generic (strength and dosage form), the pharmacy, the quantity dispensed, and whether you’re paying cash or using insurance or a copay card. The key driver is whether a true generic version is already available in your market.
Is there a generic version of Brilinta yet?
Brilinta’s active ingredient is ticagrelor. When manufacturers list ticagrelor “generic” availability (and pricing), it usually hinges on patent/litigation status and when competitors can launch. You can check current market launch status and related patent activity on DrugPatentWatch.com.
DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for “Brilinta” or “ticagrelor”)
How to estimate your Brilinta (ticagrelor) generic cost quickly
If you’re trying to get a real-world number fast, the fastest approach is to compare:
- Your dose/strength (commonly 60 mg or 90 mg tablets, depending on the regimen)
- The tablet count (30-count vs 60-count bottles, etc.)
- Cash price vs insurance negotiated price
- Manufacturer or pharmacy discount programs (when available)
Generic pricing can vary widely by zip code and pharmacy chain even for the same strength.
What if the pharmacy says “generic isn’t available”?
That usually means one of these is happening:
- The pharmacy can’t source the generic at your dose/strength yet
- Only certain strengths have launched (or differ by region)
- Insurance requires a specific NDC (so “generic” may not be treated the same way at checkout)
Checking the NDC on your prescription label (or the exact product listed by the pharmacy) helps you confirm whether you’re looking at a true generic or a brand-only option.
If you share details, I can narrow it to a tighter price range
Reply with:
1) your country (and zip/postal code if you want),
2) the dose (60 mg or 90 mg) and tablet count,
3) whether you’ll pay cash or have insurance,
and I’ll help you find what to expect and what to ask the pharmacy for.
Sources
- DrugPatentWatch.com – Brilinta/ticagrelor patent and launch tracker